Four Ways To Strengthen Patient Engagement And Improve Data Collection In CNS Trials

By Marie Onakomaiya, Chief Science Officer and Michelle Cinguina, Research Scientist

CNS trials cover a wide spectrum of participants and indications—from older adults with Alzheimer’s disease to pediatric participants with autism spectrum disorder and people of all ages living with neuropathic pain, migraine headaches, anxiety, depression, schizophrenia, etc. Most of these trials have diverse measures with a range of reporters, including investigators, caregivers, and participants. Each subjective endpoint introduces a level of variability and potential bias into the data that need to be mitigated. In addition, CNS trials typically require a high level of involvement and support from caregivers. And, unlike participants in other types of trials, CNS trial participants may not always maintain a high level of awareness and motivation about joining a study.

Central nervous system (CNS) trials present unique challenges in terms of patient engagement and data collection. Discover how combining behavioral science with innovative technology can reshape the success of a CNS study.